| PERIOD ENDING | 25-Jul-09 | 25-Apr-09 | 24-Jan-09 | 25-Oct-08 | | Total Revenue | 8,535,000 | 8,162,000 | 9,089,000 | 10,331,000 | | Cost of Revenue | 3,074,000 | 2,933,000 | 3,366,000 | 3,650,000 | | | Gross Profit | 5,461,000 | 5,229,000 | 5,723,000 | 6,681,000 | | | Operating Expenses | | Research Development | 1,280,000 | 1,243,000 | 1,279,000 | 1,406,000 | | Selling General and Administrative | 2,497,000 | 2,258,000 | 2,535,000 | 2,678,000 | | Non Recurring | 60,000 |
-
|
-
| 3,000 | | Others | 164,000 | 121,000 | 136,000 | 112,000 | | | | Total Operating Expenses | 4,001,000 |
-
|
-
| 4,199,000 | | | | Operating Income or Loss | 1,460,000 | 1,607,000 | 1,773,000 | 2,482,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 187,000 | 185,000 | 158,000 | 187,000 | | Earnings Before Interest And Taxes | 1,647,000 | 1,792,000 | 1,931,000 | 2,669,000 | | Interest Expense | 114,000 | 105,000 | 63,000 | 64,000 | | Income Before Tax | 1,533,000 | 1,687,000 | 1,868,000 | 2,605,000 | | Income Tax Expense | 452,000 | 339,000 | 364,000 | 404,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,081,000 | 1,348,000 | 1,504,000 | 2,201,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,081,000 | 1,348,000 | 1,504,000 | 2,201,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,081,000 | $1,348,000 | $1,504,000 | $2,201,000 |
|
2.03% Nasdaq 0.00%
Income Statement
